Global Markets for Research Antibodies
Report Scope:
This study focuses on the market side of research antibodies, as opposed to the technical side. Different market segments for this specific market are covered. Application-based market segments include enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC)(types of tissue multiplexing segments), immunofluorescent staining (IF), immunoprecipitation and flow cytometry (FC); antibody function-based market segments include primary antibodies and secondary antibodies; antibody clonality-based market segments include polyclonal antibodies and monoclonal antibodies, including recombinant antibodies; customer type-based market segments include universities and academic institutions, pharmaceutical and biotech companies and other types of customers (e.g., governmental research labs, contract research organizations [CROs]); geography-based market segments include North America, Europe, Asia-Pacific and Rest of World. Research and market trends are also extrapolated by analyzing the funding, patent publications and sales trends of major players in the field.
In this report, the market for research antibodies is segmented based on product type, clonality, host species, major reactivities, applications, end-user, and geography. Based on application type, the market is segmented into enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC) (i.e., types of tissue multiplexing segments), immunofluorescent staining (IF), immunoprecipitation and flow cytometry (FC). Based on major reactivities, the market is segmented into anti-human, anti-rat and anti-mouse. The market is also presented based on product type, which is further segmented into primary and secondary antibodies.
The market has been geographically segmented into the North America, Europe, Asia-Pacific and Rest of the World (i.e., South America, Middle East and Africa) regions. Detailed analysis of major countries (e.g., the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, and GCC countries) will be covered in the regional segment. For market estimates, data will be provided for 2022 as the base year, with estimates for 2023 and forecast value for 2028.
Report Includes:
This study focuses on the market side of research antibodies, as opposed to the technical side. Different market segments for this specific market are covered. Application-based market segments include enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC)(types of tissue multiplexing segments), immunofluorescent staining (IF), immunoprecipitation and flow cytometry (FC); antibody function-based market segments include primary antibodies and secondary antibodies; antibody clonality-based market segments include polyclonal antibodies and monoclonal antibodies, including recombinant antibodies; customer type-based market segments include universities and academic institutions, pharmaceutical and biotech companies and other types of customers (e.g., governmental research labs, contract research organizations [CROs]); geography-based market segments include North America, Europe, Asia-Pacific and Rest of World. Research and market trends are also extrapolated by analyzing the funding, patent publications and sales trends of major players in the field.
In this report, the market for research antibodies is segmented based on product type, clonality, host species, major reactivities, applications, end-user, and geography. Based on application type, the market is segmented into enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC) (i.e., types of tissue multiplexing segments), immunofluorescent staining (IF), immunoprecipitation and flow cytometry (FC). Based on major reactivities, the market is segmented into anti-human, anti-rat and anti-mouse. The market is also presented based on product type, which is further segmented into primary and secondary antibodies.
The market has been geographically segmented into the North America, Europe, Asia-Pacific and Rest of the World (i.e., South America, Middle East and Africa) regions. Detailed analysis of major countries (e.g., the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, and GCC countries) will be covered in the regional segment. For market estimates, data will be provided for 2022 as the base year, with estimates for 2023 and forecast value for 2028.
Report Includes:
- 145 data tables and 45 additional tables
- An overview of the global market landscape related to the research antibodies
- In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to research antibodies, accompanied by a comprehensive market share analysis categorized by product, clonality, application, major reactivities, host species, end-user, and geographical region
- Discussion on the factors affecting the companies’ market shares, the current strategies of antibody companies, the effect of research funding, and the third-party quality evaluation systems of research antibodies
- Discussion on technological trends in antibody production and application, and information on antibody-based drug discovery and development process
- Impact analysis of COVID-19 on entire pharma industry and discussion on how COVID-19 is related to pharmaceutical industry’s growth slow-down and results in delayed approvals for non-COVID-19-related pharmaceutical/biotech products
- Coverage of new discoveries in biological sciences, rapid technological developments in the IVD industry, new antibody technologies and antibody types, and assessment of antibody-based drug discovery and development
- Discussion on advantages and disadvantages of antibody discovery technologies with examples of antibody production, and information on REpAb technology
- Coverage of FDA and international regulations, details of recent regulatory reforms and list of antibody therapeutics granted in 2018 and insights into government initiatives and funding in emerging markets
- Examination of environmental, social, and corporate governance (ESG) developments, a relevant patent analysis; and merger and acquisitions (M&A), venture fundings, and emerging technologies in the global research antibodies
- Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses, including Abcam Plc, Thermo Fisher Scientific Inc., Cell Signaling Technology Inc., Merck KGaA, Sino Biological Inc., and Bio-Rad
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in this Update
Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Market Overview
Market Summary
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
Introduction
History and Current State
Background of the Antibody and Its Production
Current Status and Issues
Overview of Antibody Technology
Traditional Antibody Generation Technologies
Antibody Generation Technologies
Antibody Validation Methods
Trends in the Market for Research Antibodies
Purchasing Factors Analysis
Third-Party Quality Evaluation Systems
Research Grants
Journal Citations Analysis
Technological Trends in Antibody Production and Application
CHAPTER 4 RESEARCH ANTIBODIES
Introduction
Enzyme-Linked Immunosorbent Assay/Enzyme-Linked Immunosorbent Spot
Direct ELISA
Indirect ELISA
Competitive ELISA
Sandwich ELISA
ELISPOT Assays
FluoroSpot Assays
Emerging Technologies or Platforms in ELISA
Western Blot
One-Dimensional Gel Electrophoresis
Two-Dimensional Gel Electrophoresis
Emerging Technologies and Platforms in Western Blot
Immunohistochemistry
Multiplexed Staining
Low-Flexed Staining
Flow Cytometry
Emerging Technologies/Platforms in Flow Cytometry
Immunocytochemistry and Immunofluorescent Staining
Chromatin Immunoprecipitation
Other Antibody Applications
Antibody Arrays
CHAPTER 5 MARKET DYNAMICS
Market Drivers
New Discoveries in Biological Sciences
Rapid Technological Developments in the In Vitro Diagnostic Industry
New Antibody Technologies and Types
Antibody-Based Drug Discovery and Development
Developed and Increasing Research Areas
Increased Government Funding in Emerging Markets
Need for Further Human Genomic and Proteomic Research
Need for Quality Antibodies in the Current Research Community
Need for Antibody Custom Services
New Application-Focused Technology Platforms
Market Restraints
Limited Research Funding
Low Validation Technologies
Decline in Suppliers
Decrease in Market Acceptance or Brand Trust
Market and Economic Risk
Market Opportunities
Market Expansion into Emerging Countries
Development of Novel Research Antibodies
CHAPTER 6 MARKET BREAKDOWN BY TYPE OF ANTIBODY
Global Market for Research Antibodies by Type
Primary Antibodies
Secondary Antibodies
CHAPTER 7 MARKET BREAKDOWN BY CLONALITY
Global Market for Research Antibodies by Clonality
Polyclonal Antibodies
Monoclonal Antibodies
Recombinant Antibodies
CHAPTER 8 MARKET BREAKDOWN BY MAJOR REACTIVITY
Global Market for Research Antibodies by Major Reactivity
Human (Anti-Human)
Mouse (Anti-Mouse)
Rat (Anti-Rat)
Others
CHAPTER 9 MARKET BREAKDOWN BY APPLICATION
Global Market for Research Antibodies by Application
Western Blot
Flow Cytometry
Immunohistochemistry
Immunocytochemistry
Immunofluorescent Staining
Immunoprecipitation
ELISA
CHAPTER 10 MARKET BREAKDOWN BY HOST SPECIES
Global Market for Research Antibodies by Host Species
Rabbit Host Species
Goat Host Species
Mouse-Host Species
Sheep Host Species
Donkey Host Species
Other Host Species
CHAPTER 11 MARKET BREAKDOWN BY END USER
Global Market for Research Antibodies by End User
Universities and Academic Institutions
Pharma and Biotech Companies
Other End Users
CHAPTER 12 MARKET BREAKDOWN BY REGION
Global Market for Research Antibodies by Region
North America
Europe
Asia-Pacific
Rest of World
CHAPTER 13 SUSTAINABILITY IN THE RESEARCH ANTIBODIES INDUSTRY: AN ENVIRONMENT, SOCIAL AND GOVERNANCE SUSTAINABILITY IN THE RESEARCH
Importance of Environment, Social and Governance in the Research Antibodies Manufacturing Industry
Environment, Social and Governance Ratings and Metrics: Understanding the Data
Environmental, Social and Governance Practices in the Research Antibodies Manufacturing Industry
Environmental Performance
Social Performance
Governance Performance
Case Studies
BCC Research Viewpoint
CHAPTER 14 EMERGING TECHNOLOGY FOR ANTIBODY DISCOVERY AND GENERATION
Traditional Antibody Discovery and Generation Technologies
Animal Plasma Isolation
Hybridoma Generation
B Cell Screening
Display Technologies
Emerging Antibody Discovery and Generation Technologies
Emerging Trends in the Antibody Production Technologies
Polyclonal Antibody Sequencing
Single B Cell Sequencing
Machine Learning-Assisted Discovery and Generation
Advantages and Disadvantages of Antibody Discovery Technol0gies
Examples of Antibody Production and Technologies
REpAb Technology
Boehringer Ingelheim’s Partnership with Company
COVID-19 Vaccines by EABR Technology
First Therapeutic Antibody
Challenges and Future Research Direction
CHAPTER 15 APPROVED MONOCLONAL ANTIBODIES, 2018-2023
CHAPTER 16 M&A AND VENTURE FUNDING OUTLOOK
Mergers and Acquisitions Analysis
Merger and Acquisition Deals: 2018–2023
CHAPTER 17 COMPETITIVE LANDSCAPE
Global Company Market Ranking
Distribution of the WHO’s International Standard for Anti-SARS-CoV-2 Immunoglobulin
Top 100 Antibodies by Major Key Companies
CHAPTER 18 COMPANY PROFILES
ABCAM PLC
ABSOLUTE ANTIBODY LTD.
AGILENT TECHNOLOGIES INC.
BD BIOSCIENCES
BIO-RAD (ABD SEROTEC)
BIO-TECHNE
CELL SIGNALING TECHNOLOGY INC.
DANAHER
JACKSON IMMUNORESEARCH LABORATORIES INC.
LONZA
MERCK KGAA (SIGMA-MILLIPORE)
ROCKLAND IMMUNOCHEMICALS INC.
SANTA CRUZ BIOTECHNOLOGY INC.
SINO BIOLOGICAL INC.
THERMO FISHER SCIENTIFIC INC.
UNITED STATES BIOLOGICAL
CHAPTER 19 APPENDIX: ACRONYMS
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in this Update
Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Market Overview
Market Summary
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
Introduction
History and Current State
Background of the Antibody and Its Production
Current Status and Issues
Overview of Antibody Technology
Traditional Antibody Generation Technologies
Antibody Generation Technologies
Antibody Validation Methods
Trends in the Market for Research Antibodies
Purchasing Factors Analysis
Third-Party Quality Evaluation Systems
Research Grants
Journal Citations Analysis
Technological Trends in Antibody Production and Application
CHAPTER 4 RESEARCH ANTIBODIES
Introduction
Enzyme-Linked Immunosorbent Assay/Enzyme-Linked Immunosorbent Spot
Direct ELISA
Indirect ELISA
Competitive ELISA
Sandwich ELISA
ELISPOT Assays
FluoroSpot Assays
Emerging Technologies or Platforms in ELISA
Western Blot
One-Dimensional Gel Electrophoresis
Two-Dimensional Gel Electrophoresis
Emerging Technologies and Platforms in Western Blot
Immunohistochemistry
Multiplexed Staining
Low-Flexed Staining
Flow Cytometry
Emerging Technologies/Platforms in Flow Cytometry
Immunocytochemistry and Immunofluorescent Staining
Chromatin Immunoprecipitation
Other Antibody Applications
Antibody Arrays
CHAPTER 5 MARKET DYNAMICS
Market Drivers
New Discoveries in Biological Sciences
Rapid Technological Developments in the In Vitro Diagnostic Industry
New Antibody Technologies and Types
Antibody-Based Drug Discovery and Development
Developed and Increasing Research Areas
Increased Government Funding in Emerging Markets
Need for Further Human Genomic and Proteomic Research
Need for Quality Antibodies in the Current Research Community
Need for Antibody Custom Services
New Application-Focused Technology Platforms
Market Restraints
Limited Research Funding
Low Validation Technologies
Decline in Suppliers
Decrease in Market Acceptance or Brand Trust
Market and Economic Risk
Market Opportunities
Market Expansion into Emerging Countries
Development of Novel Research Antibodies
CHAPTER 6 MARKET BREAKDOWN BY TYPE OF ANTIBODY
Global Market for Research Antibodies by Type
Primary Antibodies
Secondary Antibodies
CHAPTER 7 MARKET BREAKDOWN BY CLONALITY
Global Market for Research Antibodies by Clonality
Polyclonal Antibodies
Monoclonal Antibodies
Recombinant Antibodies
CHAPTER 8 MARKET BREAKDOWN BY MAJOR REACTIVITY
Global Market for Research Antibodies by Major Reactivity
Human (Anti-Human)
Mouse (Anti-Mouse)
Rat (Anti-Rat)
Others
CHAPTER 9 MARKET BREAKDOWN BY APPLICATION
Global Market for Research Antibodies by Application
Western Blot
Flow Cytometry
Immunohistochemistry
Immunocytochemistry
Immunofluorescent Staining
Immunoprecipitation
ELISA
CHAPTER 10 MARKET BREAKDOWN BY HOST SPECIES
Global Market for Research Antibodies by Host Species
Rabbit Host Species
Goat Host Species
Mouse-Host Species
Sheep Host Species
Donkey Host Species
Other Host Species
CHAPTER 11 MARKET BREAKDOWN BY END USER
Global Market for Research Antibodies by End User
Universities and Academic Institutions
Pharma and Biotech Companies
Other End Users
CHAPTER 12 MARKET BREAKDOWN BY REGION
Global Market for Research Antibodies by Region
North America
Europe
Asia-Pacific
Rest of World
CHAPTER 13 SUSTAINABILITY IN THE RESEARCH ANTIBODIES INDUSTRY: AN ENVIRONMENT, SOCIAL AND GOVERNANCE SUSTAINABILITY IN THE RESEARCH
Importance of Environment, Social and Governance in the Research Antibodies Manufacturing Industry
Environment, Social and Governance Ratings and Metrics: Understanding the Data
Environmental, Social and Governance Practices in the Research Antibodies Manufacturing Industry
Environmental Performance
Social Performance
Governance Performance
Case Studies
BCC Research Viewpoint
CHAPTER 14 EMERGING TECHNOLOGY FOR ANTIBODY DISCOVERY AND GENERATION
Traditional Antibody Discovery and Generation Technologies
Animal Plasma Isolation
Hybridoma Generation
B Cell Screening
Display Technologies
Emerging Antibody Discovery and Generation Technologies
Emerging Trends in the Antibody Production Technologies
Polyclonal Antibody Sequencing
Single B Cell Sequencing
Machine Learning-Assisted Discovery and Generation
Advantages and Disadvantages of Antibody Discovery Technol0gies
Examples of Antibody Production and Technologies
REpAb Technology
Boehringer Ingelheim’s Partnership with Company
COVID-19 Vaccines by EABR Technology
First Therapeutic Antibody
Challenges and Future Research Direction
CHAPTER 15 APPROVED MONOCLONAL ANTIBODIES, 2018-2023
CHAPTER 16 M&A AND VENTURE FUNDING OUTLOOK
Mergers and Acquisitions Analysis
Merger and Acquisition Deals: 2018–2023
CHAPTER 17 COMPETITIVE LANDSCAPE
Global Company Market Ranking
Distribution of the WHO’s International Standard for Anti-SARS-CoV-2 Immunoglobulin
Top 100 Antibodies by Major Key Companies
CHAPTER 18 COMPANY PROFILES
ABCAM PLC
ABSOLUTE ANTIBODY LTD.
AGILENT TECHNOLOGIES INC.
BD BIOSCIENCES
BIO-RAD (ABD SEROTEC)
BIO-TECHNE
CELL SIGNALING TECHNOLOGY INC.
DANAHER
JACKSON IMMUNORESEARCH LABORATORIES INC.
LONZA
MERCK KGAA (SIGMA-MILLIPORE)
ROCKLAND IMMUNOCHEMICALS INC.
SANTA CRUZ BIOTECHNOLOGY INC.
SINO BIOLOGICAL INC.
THERMO FISHER SCIENTIFIC INC.
UNITED STATES BIOLOGICAL
CHAPTER 19 APPENDIX: ACRONYMS
LIST OF TABLES
Summary Table : Global Market for Research Antibodies, by Application, Through 2028
Table 1 : Most-Cited Antibodies and Their Suppliers, 2022
Table 2 : Global Market for Research Antibodies, by Type of Antibody, Through 2028
Table 3 : Clinically Therapeutic Monoclonal Antibodies
Table 4 : Global Market for Primary Antibodies, by Region, Through 2028
Table 5 : Secondary Antibody Selection
Table 6 : Global Market for Secondary Antibodies, by Region, Through 2028
Table 7 : Global Market for Research Antibodies, by Clonality, Through 2028
Table 8 : Global Market for Polyclonal Antibodies, by Region, Through 2028
Table 9 : Global Market for Monoclonal Antibodies, by Region, Through 2028
Table 10 : Global Market for Recombinant Antibodies, by Region, Through 2028
Table 11 : Global Market for Research Antibodies, by Major Reactivity, Through 2028
Table 12 : Global Market for Anti-Human Antibodies, by Region, Through 2028
Table 13 : Global Market for Anti-Mouse Antibodies, by Region, Through 2028
Table 14 : Rat Antibodies with Different Isotypes.
Table 15 : Global Market for Anti-Rat Antibodies, by Region, Through 2028
Table 16 : Other Antibodies with Different Isotypes.
Table 17 : Global Market for Other Research Antibodies, by Region, Through 2028
Table 18 : Global Market for Research Antibodies, by Application, Through 2028
Table 19 : Global Market for Western Blot Applications, by Region, Through 2028
Table 20 : Global Market for Flow Cytometry Applications, by Region, Through 2028
Table 21 : Global Market for Immunohistochemistry Applications, by Region, Through 2028
Table 22 : Global Market for Multiplex Staining Applications, by Region, Through 2028
Table 23 : Global Market for Low-Flexed Staining Applications, by Region, Through 2028
Table 24 : Global Market for Immunocytochemistry Staining Applications, by Region, Through 2028
Table 25 : Global Market for Immunofluorescent Applications, by Region, Through 2028
Table 26 : Global Market for Immunoprecipitation Applications, by Region, Through 2028
Table 27 : Global Market for ELISA Applications, by Region, Through 2028
Table 28 : Global Market for Research Antibodies, by Host Species, Through 2028
Table 29 : Global Market for Rabbit Research Antibodies, by Region, Through 2028
Table 30 : Global Market for Goat Research Antibodies, by Region, Through 2028
Table 31 : Global Market for Mouse Research Antibodies, by Region, Through 2028
Table 32 : Global Market for Sheep Research Antibodies, by Region, Through 2028
Table 33 : Global Market for Donkey Research Antibodies, by Region, Through 2028
Table 34 : Global Market for Other Research Antibodies, by Region, Through 2028
Table 35 : Global Market for Research Antibodies, by End User, Through 2028
Table 36 : Global Market for Research Antibodies Used by Universities and Academic Institutions, by Region, Through 2028
Table 37 : Global Market for Research Antibodies Used by Pharma and Biotech Companies, by Region, Through 2028
Table 38 : Global Market for Research Antibodies Used by Other End Users, by Region, Through 2028
Table 39 : Global Market for Research Antibodies, by Region, Through 2028
Table 40 : U.S. Grants for Research, by Type of Cancer, 2023
Table 41 : North American Market for Research Antibodies, by Country, Through 2028
Table 42 : U.S. Market for Research Antibodies, by Type of Antibody, Through 2028
Table 43 : U.S. Market for Research Antibodies, by Clonality, Through 2028
Table 44 : U.S. Market for Research Antibodies, by Major Reactivity, Through 2028
Table 45 : U.S. Market for Research Antibodies, by Application, Through 2028
Table 46 : U.S. Market for Research Antibodies, by Host Species, Through 2028
Table 47 : U.S. Market for Research Antibodies, by End User, Through 2028
Table 48 : Canadian Market for Research Antibodies, by Type of Antibody, Through 2028
Table 49 : Canadian Market for Research Antibodies, by Clonality, Through 2028
Table 50 : Canadian Market for Research Antibodies, by Major Reactivity, Through 2028
Table 51 : Canadian Market for Research Antibodies, by Application, Through 2028
Table 52 : Canadian Market for Research Antibodies, by Host Species, Through 2028
Table 53 : Canadian Market for Research Antibodies, by End User, Through 2028
Table 54 : Estimated Top New Cancer Cases in Canada, 2022
Table 55 : Mexican Market for Research Antibodies, by Type of Antibody, Through 2028
Table 56 : Mexican Market for Research Antibodies, by Clonality, Through 2028
Table 57 : Mexican Market for Research Antibodies, by Major Reactivity, Through 2028
Table 58 : Mexican Market for Research Antibodies, by Application, Through 2028
Table 59 : Mexican Market for Research Antibodies, by Host Species, Through 2028
Table 60 : Mexican Market for Research Antibodies, by End User, Through 2028
Table 61 : European Market for Research Antibodies, by Country, Through 2028
Table 62 : German Market for Research Antibodies, by Type of Antibody, Through 2028
Table 63 : German Market for Research Antibodies, by Clonality, Through 2028
Table 64 : German Market for Research Antibodies, by Major Reactivity, Through 2028
Table 65 : German Market for Research Antibodies, by Application, Through 2028
Table 66 : German Market for Research Antibodies, by Host Species, Through 2028
Table 67 : German Market for Research Antibodies, by End User, Through 2028
Table 68 : French Market for Research Antibodies, by Type of Antibody, Through 2028
Table 69 : French Market for Research Antibodies, by Clonality, Through 2028
Table 70 : French Market for Research Antibodies, by Major Reactivity, Through 2028
Table 71 : French Market for Research Antibodies, by Application, Through 2028
Table 72 : French Market for Research Antibodies, by Host Species, Through 2028
Table 73 : French Market for Research Antibodies, by End User, Through 2028
Table 74 : U.K. Market for Research Antibodies, by Type of Antibody, Through 2028
Table 75 : U.K. Market for Research Antibodies, by Clonality, Through 2028
Table 76 : U.K. Market for Research Antibodies, by Major Reactivity, Through 2028
Table 77 : U.K. Market for Research Antibodies, by Application, Through 2028
Table 78 : U.K. Market for Research Antibodies, by Host Species, Through 2028
Table 79 : U.K. Market for Research Antibodies, by End User, Through 2028
Table 80 : Italian Market for Research Antibodies, by Type of Antibody, Through 2028
Table 81 : Italian Market for Research Antibodies, by Clonality, Through 2028
Table 82 : Italian Market for Research Antibodies, by Major Reactivity, Through 2028
Table 83 : Italian Market for Research Antibodies, by Application, Through 2028
Table 84 : Italian Market for Research Antibodies, by Host Species, Through 2028
Table 85 : Italian Market for Research Antibodies, by End User, Through 2028
Table 86 : Spanish Market for Research Antibodies, by Type of Antibody, Through 2028
Table 87 : Spanish Market for Research Antibodies, by Clonality, Through 2028
Table 88 : Spanish Market for Research Antibodies, by Major Reactivity, Through 2028
Table 89 : Spanish Market for Research Antibodies, by Application, Through 2028
Table 90 : Spanish Market for Research Antibodies, by Host Species, Through 2028
Table 91 : Spanish Market for Research Antibodies, by End User, Through 2028
Table 92 : Rest of European Market for Research Antibodies, by Type of Antibody, Through 2028
Table 93 : Rest of European Market for Research Antibodies, by Clonality, Through 2028
Table 94 : Rest of European Market for Research Antibodies, by Major Reactivity, Through 2028
Table 95 : Rest of European Market for Research Antibodies, by Application, Through 2028
Table 96 : Rest of European Market for Research Antibodies, by Host Species, Through 2028
Table 97 : Rest of European Market for Research Antibodies, by End User, Through 2028
Table 98 : Asia-Pacific Market for Research Antibodies, by Country, Through 2028
Table 99 : Japanese Market for Research Antibodies, by Type of Antibody, Through 2028
Table 100 : Japanese Market for Research Antibodies, by Clonality, Through 2028
Table 101 : Japanese Market for Research Antibodies, by Major Reactivity, Through 2028
Table 102 : Japanese Market for Research Antibodies, by Application, Through 2028
Table 103 : Japanese Market for Research Antibodies, by Host Species, Through 2028
Table 104 : Japanese Market for Research Antibodies, by End User, Through 2028
Table 105 : Top Five Research Institutions in Japan in Antibody Use,2022
Table 106 : Chinese Market for Research Antibodies, by Type of Antibody, Through 2028
Table 107 : Chinese Market for Research Antibodies, by Clonality, Through 2028
Table 108 : Chinese Market for Research Antibodies, by Major Reactivity, Through 2028
Table 109 : Chinese Market for Research Antibodies, by Application, Through 2028
Table 110 : Chinese Market for Research Antibodies, by Host Species, Through 2028
Table 111 : Chinese Market for Research Antibodies, by End User, Through 2028
Table 112 : Indian Market for Research Antibodies, by Type of Antibody, Through 2028
Table 113 : Indian Market for Research Antibodies, by Clonality, Through 2028
Table 114 : Indian Market for Research Antibodies, by Major Reactivity, Through 2028
Table 115 : Indian Market for Research Antibodies, by Application, Through 2028
Table 116 : Indian Market for Research Antibodies, by Host Species, Through 2028
Table 117 : Indian Market for Research Antibodies, by End User, Through 2028
Table 118 : Australian and New Zealand Market for Research Antibodies, by Type of Antibody, Through 2028
Table 119 : Australian and New Zealand Market for Research Antibodies, by Clonality, Through 2028
Table 120 : Australian and New Zealand Market for Research Antibodies, by Major Reactivity, Through 2028
Table 121 : Australian and New Zealand Market for Research Antibodies, by Application, Through 2028
Table 122 : Australian and New Zealand Market for Research Antibodies, by Host Species, Through 2028
Table 123 : Australian and New Zealand Market for Research Antibodies, by End User, Through 2028
Table 124 : Rest of Asia-Pacific Market for Research Antibodies, by Type of Antibody, Through 2028
Table 125 : Rest of Asia-Pacific Market for Research Antibodies, by Clonality, Through 2028
Table 126 : Rest of Asia-Pacific Market for Research Antibodies, by Major Reactivity, Through 2028
Table 127 : Rest of Asia-Pacific Market for Research Antibodies, by Application, Through 2028
Table 128 : Rest of Asia-Pacific Market for Research Antibodies, by Host Species, Through 2028
Table 129 : Rest of Asia-Pacific Market for Research Antibodies, by End User, Through 2028
Table 130 : Rest of World Market for Research Antibodies, by Country/Region, Through 2028
Table 131 : Brazilian Market for Research Antibodies, by Type of Antibody, Through 2028
Table 132 : Brazilian Market for Research Antibodies, by Clonality, Through 2028
Table 133 : Brazilian Market for Research Antibodies, by Major Reactivity, Through 2028
Table 134 : Brazilian Market for Research Antibodies, by Application, Through 2028
Table 135 : Brazilian Market for Research Antibodies, by Host Species, Through 2028
Table 136 : Brazilian Market for Research Antibodies, by End User, Through 2028
Table 137 : GCC countries Market for Research Antibodies, by Type of Antibody, Through 2028
Table 138 : GCC Countries Market for Research Antibodies, by Clonality, Through 2028
Table 139 : GCC Countries Market for Research Antibodies, by Major Reactivity, Through 2028
Table 140 : GCC Countries Market for Research Antibodies, by Application, Through 2028
Table 141 : GCC Countries Market for Research Antibodies, by Host Species, Through 2028
Table 142 : GCC Countries Market for Research Antibodies, by End User, Through 2028
Table 143 : Rest of World Countries Market for Research Antibodies, by Type of Antibody, Through 2028
Table 144 : Rest of World Countries Market for Research Antibodies, by Clonality, Through 2028
Table 145 : Rest of World Countries Market for Research Antibodies, by Major Reactivity, Through 2028
Table 146 : Rest of World Countries Market for Research Antibodies, by Application, Through 2028
Table 147 : Rest of World Countries Market for Research Antibodies, by Host Species, Through 2028
Table 148 : Rest of World Countries Market for Research Antibodies, by End User, Through 2028
Table 149 : Environmental, Social and Governance Ratings and Metrics
Table 150 : Environmental, Social and Governance Practices: Environmental Performance
Table 151 : Environmental, Social and Governance Practices: Social Performance
Table 152 : Environmental, Social and Governance Practices: Governance Performance
Table 153 : Recent Awards to Major Companies
Table 154 : Environmental, Social and Governance Rankings for Major Research Antibodies Companies, 2023*
Table 155 : Emerging Trends
Table 156 : Antibody Structure Modeling Methods
Table 157 : Current Computational Databases and Tools for Analysis and Prediction of Antibody Structure, Sequence and Properties
Table 158 : FDA-Approved Monoclonal Antibodies in the Market
Table 159 : Regional Distribution of Manufacturing Capacity, by Mammalian Cell Culture Capacity, 2002–2022
Table 160 : Regional Distribution of Manufacturing Capacity, by Noninsulin Microbial Capacity, 2002–2022
Table 161 : Abcam Plc: Company Snapshot
Table 162 : Abcam plc: Product Portfolio
Table 163 : Absolute Antibody Ltd.: Product Portfolio
Table 164 : Agilent Technologies: Company Snapshot
Table 165 : Agilent Technologies Inc.: Product Portfolio
Table 166 : BD Biosciences: Company Snapshot
Table 167 : BD Biosciences: Product Portfolio
Table 168 : Bio-Rad: Company Snapshot
Table 169 : Bio-Rad: Product Portfolio
Table 170 : Bio-Techne: Company Snapshot
Table 171 : Bio-Techne: Product Portfolio
Table 172 : Cell Signaling Technology Inc.: Product Portfolio, by Type
Table 173 : Cell Signaling Technology Inc.: Products Portfolio, by Source
Table 174 : Danaher: Company Snapshot
Table 175 : Danaher (Beckman Coulter Inc.): Product Portfolio
Table 176 : Jackson ImmunoResearch Laboratories: Product Portfolio
Table 177 : Lonza: Company Snapshot
Table 178 : Lonza: Product Portfolio
Table 179 : Merck KGAA (Sigma-Millipore): Company Snapshot
Table 180 : Merck KGAA (Sigma-Millipore): Product Portfolio
Table 181 : Rockland Immunochemical Inc.: Product Portfolio
Table 182 : Santa Cruz Biotechnology Inc.: Product Portfolio
Table 183 : Sino Biological Inc.: Company Snapshot
Table 184 : Sino Biological Inc.: Product Portfolio
Table 185 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 186 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 187 : United States Biological: Product Portfolio
Table 188 : United States Biological: Product Portfolio Description
Table 189 : Acronyms Used in This Report
Summary Table : Global Market for Research Antibodies, by Application, Through 2028
Table 1 : Most-Cited Antibodies and Their Suppliers, 2022
Table 2 : Global Market for Research Antibodies, by Type of Antibody, Through 2028
Table 3 : Clinically Therapeutic Monoclonal Antibodies
Table 4 : Global Market for Primary Antibodies, by Region, Through 2028
Table 5 : Secondary Antibody Selection
Table 6 : Global Market for Secondary Antibodies, by Region, Through 2028
Table 7 : Global Market for Research Antibodies, by Clonality, Through 2028
Table 8 : Global Market for Polyclonal Antibodies, by Region, Through 2028
Table 9 : Global Market for Monoclonal Antibodies, by Region, Through 2028
Table 10 : Global Market for Recombinant Antibodies, by Region, Through 2028
Table 11 : Global Market for Research Antibodies, by Major Reactivity, Through 2028
Table 12 : Global Market for Anti-Human Antibodies, by Region, Through 2028
Table 13 : Global Market for Anti-Mouse Antibodies, by Region, Through 2028
Table 14 : Rat Antibodies with Different Isotypes.
Table 15 : Global Market for Anti-Rat Antibodies, by Region, Through 2028
Table 16 : Other Antibodies with Different Isotypes.
Table 17 : Global Market for Other Research Antibodies, by Region, Through 2028
Table 18 : Global Market for Research Antibodies, by Application, Through 2028
Table 19 : Global Market for Western Blot Applications, by Region, Through 2028
Table 20 : Global Market for Flow Cytometry Applications, by Region, Through 2028
Table 21 : Global Market for Immunohistochemistry Applications, by Region, Through 2028
Table 22 : Global Market for Multiplex Staining Applications, by Region, Through 2028
Table 23 : Global Market for Low-Flexed Staining Applications, by Region, Through 2028
Table 24 : Global Market for Immunocytochemistry Staining Applications, by Region, Through 2028
Table 25 : Global Market for Immunofluorescent Applications, by Region, Through 2028
Table 26 : Global Market for Immunoprecipitation Applications, by Region, Through 2028
Table 27 : Global Market for ELISA Applications, by Region, Through 2028
Table 28 : Global Market for Research Antibodies, by Host Species, Through 2028
Table 29 : Global Market for Rabbit Research Antibodies, by Region, Through 2028
Table 30 : Global Market for Goat Research Antibodies, by Region, Through 2028
Table 31 : Global Market for Mouse Research Antibodies, by Region, Through 2028
Table 32 : Global Market for Sheep Research Antibodies, by Region, Through 2028
Table 33 : Global Market for Donkey Research Antibodies, by Region, Through 2028
Table 34 : Global Market for Other Research Antibodies, by Region, Through 2028
Table 35 : Global Market for Research Antibodies, by End User, Through 2028
Table 36 : Global Market for Research Antibodies Used by Universities and Academic Institutions, by Region, Through 2028
Table 37 : Global Market for Research Antibodies Used by Pharma and Biotech Companies, by Region, Through 2028
Table 38 : Global Market for Research Antibodies Used by Other End Users, by Region, Through 2028
Table 39 : Global Market for Research Antibodies, by Region, Through 2028
Table 40 : U.S. Grants for Research, by Type of Cancer, 2023
Table 41 : North American Market for Research Antibodies, by Country, Through 2028
Table 42 : U.S. Market for Research Antibodies, by Type of Antibody, Through 2028
Table 43 : U.S. Market for Research Antibodies, by Clonality, Through 2028
Table 44 : U.S. Market for Research Antibodies, by Major Reactivity, Through 2028
Table 45 : U.S. Market for Research Antibodies, by Application, Through 2028
Table 46 : U.S. Market for Research Antibodies, by Host Species, Through 2028
Table 47 : U.S. Market for Research Antibodies, by End User, Through 2028
Table 48 : Canadian Market for Research Antibodies, by Type of Antibody, Through 2028
Table 49 : Canadian Market for Research Antibodies, by Clonality, Through 2028
Table 50 : Canadian Market for Research Antibodies, by Major Reactivity, Through 2028
Table 51 : Canadian Market for Research Antibodies, by Application, Through 2028
Table 52 : Canadian Market for Research Antibodies, by Host Species, Through 2028
Table 53 : Canadian Market for Research Antibodies, by End User, Through 2028
Table 54 : Estimated Top New Cancer Cases in Canada, 2022
Table 55 : Mexican Market for Research Antibodies, by Type of Antibody, Through 2028
Table 56 : Mexican Market for Research Antibodies, by Clonality, Through 2028
Table 57 : Mexican Market for Research Antibodies, by Major Reactivity, Through 2028
Table 58 : Mexican Market for Research Antibodies, by Application, Through 2028
Table 59 : Mexican Market for Research Antibodies, by Host Species, Through 2028
Table 60 : Mexican Market for Research Antibodies, by End User, Through 2028
Table 61 : European Market for Research Antibodies, by Country, Through 2028
Table 62 : German Market for Research Antibodies, by Type of Antibody, Through 2028
Table 63 : German Market for Research Antibodies, by Clonality, Through 2028
Table 64 : German Market for Research Antibodies, by Major Reactivity, Through 2028
Table 65 : German Market for Research Antibodies, by Application, Through 2028
Table 66 : German Market for Research Antibodies, by Host Species, Through 2028
Table 67 : German Market for Research Antibodies, by End User, Through 2028
Table 68 : French Market for Research Antibodies, by Type of Antibody, Through 2028
Table 69 : French Market for Research Antibodies, by Clonality, Through 2028
Table 70 : French Market for Research Antibodies, by Major Reactivity, Through 2028
Table 71 : French Market for Research Antibodies, by Application, Through 2028
Table 72 : French Market for Research Antibodies, by Host Species, Through 2028
Table 73 : French Market for Research Antibodies, by End User, Through 2028
Table 74 : U.K. Market for Research Antibodies, by Type of Antibody, Through 2028
Table 75 : U.K. Market for Research Antibodies, by Clonality, Through 2028
Table 76 : U.K. Market for Research Antibodies, by Major Reactivity, Through 2028
Table 77 : U.K. Market for Research Antibodies, by Application, Through 2028
Table 78 : U.K. Market for Research Antibodies, by Host Species, Through 2028
Table 79 : U.K. Market for Research Antibodies, by End User, Through 2028
Table 80 : Italian Market for Research Antibodies, by Type of Antibody, Through 2028
Table 81 : Italian Market for Research Antibodies, by Clonality, Through 2028
Table 82 : Italian Market for Research Antibodies, by Major Reactivity, Through 2028
Table 83 : Italian Market for Research Antibodies, by Application, Through 2028
Table 84 : Italian Market for Research Antibodies, by Host Species, Through 2028
Table 85 : Italian Market for Research Antibodies, by End User, Through 2028
Table 86 : Spanish Market for Research Antibodies, by Type of Antibody, Through 2028
Table 87 : Spanish Market for Research Antibodies, by Clonality, Through 2028
Table 88 : Spanish Market for Research Antibodies, by Major Reactivity, Through 2028
Table 89 : Spanish Market for Research Antibodies, by Application, Through 2028
Table 90 : Spanish Market for Research Antibodies, by Host Species, Through 2028
Table 91 : Spanish Market for Research Antibodies, by End User, Through 2028
Table 92 : Rest of European Market for Research Antibodies, by Type of Antibody, Through 2028
Table 93 : Rest of European Market for Research Antibodies, by Clonality, Through 2028
Table 94 : Rest of European Market for Research Antibodies, by Major Reactivity, Through 2028
Table 95 : Rest of European Market for Research Antibodies, by Application, Through 2028
Table 96 : Rest of European Market for Research Antibodies, by Host Species, Through 2028
Table 97 : Rest of European Market for Research Antibodies, by End User, Through 2028
Table 98 : Asia-Pacific Market for Research Antibodies, by Country, Through 2028
Table 99 : Japanese Market for Research Antibodies, by Type of Antibody, Through 2028
Table 100 : Japanese Market for Research Antibodies, by Clonality, Through 2028
Table 101 : Japanese Market for Research Antibodies, by Major Reactivity, Through 2028
Table 102 : Japanese Market for Research Antibodies, by Application, Through 2028
Table 103 : Japanese Market for Research Antibodies, by Host Species, Through 2028
Table 104 : Japanese Market for Research Antibodies, by End User, Through 2028
Table 105 : Top Five Research Institutions in Japan in Antibody Use,2022
Table 106 : Chinese Market for Research Antibodies, by Type of Antibody, Through 2028
Table 107 : Chinese Market for Research Antibodies, by Clonality, Through 2028
Table 108 : Chinese Market for Research Antibodies, by Major Reactivity, Through 2028
Table 109 : Chinese Market for Research Antibodies, by Application, Through 2028
Table 110 : Chinese Market for Research Antibodies, by Host Species, Through 2028
Table 111 : Chinese Market for Research Antibodies, by End User, Through 2028
Table 112 : Indian Market for Research Antibodies, by Type of Antibody, Through 2028
Table 113 : Indian Market for Research Antibodies, by Clonality, Through 2028
Table 114 : Indian Market for Research Antibodies, by Major Reactivity, Through 2028
Table 115 : Indian Market for Research Antibodies, by Application, Through 2028
Table 116 : Indian Market for Research Antibodies, by Host Species, Through 2028
Table 117 : Indian Market for Research Antibodies, by End User, Through 2028
Table 118 : Australian and New Zealand Market for Research Antibodies, by Type of Antibody, Through 2028
Table 119 : Australian and New Zealand Market for Research Antibodies, by Clonality, Through 2028
Table 120 : Australian and New Zealand Market for Research Antibodies, by Major Reactivity, Through 2028
Table 121 : Australian and New Zealand Market for Research Antibodies, by Application, Through 2028
Table 122 : Australian and New Zealand Market for Research Antibodies, by Host Species, Through 2028
Table 123 : Australian and New Zealand Market for Research Antibodies, by End User, Through 2028
Table 124 : Rest of Asia-Pacific Market for Research Antibodies, by Type of Antibody, Through 2028
Table 125 : Rest of Asia-Pacific Market for Research Antibodies, by Clonality, Through 2028
Table 126 : Rest of Asia-Pacific Market for Research Antibodies, by Major Reactivity, Through 2028
Table 127 : Rest of Asia-Pacific Market for Research Antibodies, by Application, Through 2028
Table 128 : Rest of Asia-Pacific Market for Research Antibodies, by Host Species, Through 2028
Table 129 : Rest of Asia-Pacific Market for Research Antibodies, by End User, Through 2028
Table 130 : Rest of World Market for Research Antibodies, by Country/Region, Through 2028
Table 131 : Brazilian Market for Research Antibodies, by Type of Antibody, Through 2028
Table 132 : Brazilian Market for Research Antibodies, by Clonality, Through 2028
Table 133 : Brazilian Market for Research Antibodies, by Major Reactivity, Through 2028
Table 134 : Brazilian Market for Research Antibodies, by Application, Through 2028
Table 135 : Brazilian Market for Research Antibodies, by Host Species, Through 2028
Table 136 : Brazilian Market for Research Antibodies, by End User, Through 2028
Table 137 : GCC countries Market for Research Antibodies, by Type of Antibody, Through 2028
Table 138 : GCC Countries Market for Research Antibodies, by Clonality, Through 2028
Table 139 : GCC Countries Market for Research Antibodies, by Major Reactivity, Through 2028
Table 140 : GCC Countries Market for Research Antibodies, by Application, Through 2028
Table 141 : GCC Countries Market for Research Antibodies, by Host Species, Through 2028
Table 142 : GCC Countries Market for Research Antibodies, by End User, Through 2028
Table 143 : Rest of World Countries Market for Research Antibodies, by Type of Antibody, Through 2028
Table 144 : Rest of World Countries Market for Research Antibodies, by Clonality, Through 2028
Table 145 : Rest of World Countries Market for Research Antibodies, by Major Reactivity, Through 2028
Table 146 : Rest of World Countries Market for Research Antibodies, by Application, Through 2028
Table 147 : Rest of World Countries Market for Research Antibodies, by Host Species, Through 2028
Table 148 : Rest of World Countries Market for Research Antibodies, by End User, Through 2028
Table 149 : Environmental, Social and Governance Ratings and Metrics
Table 150 : Environmental, Social and Governance Practices: Environmental Performance
Table 151 : Environmental, Social and Governance Practices: Social Performance
Table 152 : Environmental, Social and Governance Practices: Governance Performance
Table 153 : Recent Awards to Major Companies
Table 154 : Environmental, Social and Governance Rankings for Major Research Antibodies Companies, 2023*
Table 155 : Emerging Trends
Table 156 : Antibody Structure Modeling Methods
Table 157 : Current Computational Databases and Tools for Analysis and Prediction of Antibody Structure, Sequence and Properties
Table 158 : FDA-Approved Monoclonal Antibodies in the Market
Table 159 : Regional Distribution of Manufacturing Capacity, by Mammalian Cell Culture Capacity, 2002–2022
Table 160 : Regional Distribution of Manufacturing Capacity, by Noninsulin Microbial Capacity, 2002–2022
Table 161 : Abcam Plc: Company Snapshot
Table 162 : Abcam plc: Product Portfolio
Table 163 : Absolute Antibody Ltd.: Product Portfolio
Table 164 : Agilent Technologies: Company Snapshot
Table 165 : Agilent Technologies Inc.: Product Portfolio
Table 166 : BD Biosciences: Company Snapshot
Table 167 : BD Biosciences: Product Portfolio
Table 168 : Bio-Rad: Company Snapshot
Table 169 : Bio-Rad: Product Portfolio
Table 170 : Bio-Techne: Company Snapshot
Table 171 : Bio-Techne: Product Portfolio
Table 172 : Cell Signaling Technology Inc.: Product Portfolio, by Type
Table 173 : Cell Signaling Technology Inc.: Products Portfolio, by Source
Table 174 : Danaher: Company Snapshot
Table 175 : Danaher (Beckman Coulter Inc.): Product Portfolio
Table 176 : Jackson ImmunoResearch Laboratories: Product Portfolio
Table 177 : Lonza: Company Snapshot
Table 178 : Lonza: Product Portfolio
Table 179 : Merck KGAA (Sigma-Millipore): Company Snapshot
Table 180 : Merck KGAA (Sigma-Millipore): Product Portfolio
Table 181 : Rockland Immunochemical Inc.: Product Portfolio
Table 182 : Santa Cruz Biotechnology Inc.: Product Portfolio
Table 183 : Sino Biological Inc.: Company Snapshot
Table 184 : Sino Biological Inc.: Product Portfolio
Table 185 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 186 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 187 : United States Biological: Product Portfolio
Table 188 : United States Biological: Product Portfolio Description
Table 189 : Acronyms Used in This Report
LIST OF FIGURES
Summary Figure : Global Market Shares of Research Antibodies, by Application, 2022
Figure :
Figure 1 : Global Markets for Research Antibodies Market Dynamics
Figure 2 : Global Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 3 : Global Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 4 : Global Market for Primary Antibodies, 2020–2028
Figure 5 : Global Market for Primary Antibodies, by Region, 2020–2028
Figure 6 : Global Market for Secondary Antibodies, 2020–2028
Figure 7 : Global Market for Secondary Antibodies, by Region, 2020–2028
Figure 8 : Global Market Shares of Research Antibodies, by Clonality, 2022
Figure 9 : Global Market Shares of Research Antibodies, by Clonality, 2028
Figure 10 : Global Market for Polyclonal Antibodies, 2020–2028
Figure 11 : Global Market for Polyclonal Antibodies, by Region, 2020–2028
Figure 12 : Global Market for Monoclonal Antibodies, 2020–2028
Figure 13 : Global Market for Monoclonal Antibodies, by Region, 2020–2028
Figure 14 : Global Market for Recombinant Antibodies, 2020–2028
Figure 15 : Global Market for Recombinant Antibodies, by Region, 2020–2028
Figure 16 : Global Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 17 : Global Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 18 : Global Market for Anti-Human Antibodies, 2020–2028
Figure 19 : Global Market for Anti-Human Antibodies, by Region, 2020–2028
Figure 20 : Global Market for Anti-Mouse Antibodies, 2020–2028
Figure 21 : Global Market for Anti-Mouse Antibodies, by Region, 2020–2028
Figure 22 : Global Market for Anti-Rat Antibodies, 2020–2028
Figure 23 : Global Market for Anti-Rat Antibodies, by Region, 2020–2028
Figure 24 : Global Market for Other Research Antibodies, 2020–2028
Figure 25 : Global Market for Other Research Antibodies, by Region, 2020–2028
Figure 26 : Global Market Shares of Research Antibodies, by Application, 2022
Figure 27 : Global Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 28 : Global Market Shares of Research Antibodies, by Application, 2028
Figure 29 : Global Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 30 : Global Market for Western Blot Applications, 2020–2028
Figure 31 : Global Market for Western Blot Applications, by Region, 2020–2028
Figure 32 : Global Market for Flow Cytometry Applications, 2020–2028
Figure 33 : Global Market for Flow Cytometry Applications, by Region, 2020–2028
Figure 34 : Estimated New Cases of Leukemia, Lymphoma and Myeloma, 2020
Figure 35 : Global Market for Immunohistochemistry Applications, 2020–2028
Figure 36 : Global Market for Immunohistochemistry Applications, by Region, 2020–2028
Figure 37 : Global Market for Multiplex Staining Applications, 2020–2028
Figure 38 : Global Market for Multiplex Staining Applications, by Region, 2020–2028
Figure 39 : Global Market for Low-Flexed Staining Applications, 2020–2028
Figure 40 : Global Market for Low-Flexed Staining Applications, by Region, 2020–2028
Figure 41 : Global Market for Immunocytochemistry Applications, 2020–2028
Figure 42 : Global Market for Immunocytochemistry Applications, by Region, 2020–2028
Figure 43 : Global Market for Immunofluorescent Applications, 2020–2028
Figure 44 : Global Market for Immunofluorescent Applications, by Region, 2020–2028
Figure 45 : Global Market for Immunoprecipitation Applications, 2020–2028
Figure 46 : Global Market for Immunoprecipitation Applications, by Region, 2020–2028
Figure 47 : Global Market for ELISA Applications, 2020–2028
Figure 48 : Global Market for ELISA Applications, by Region, 2020–2028
Figure 49 : Global Market Shares of Research Antibodies, by Host Species, 2022
Figure 50 : Global Market Shares of Research Antibodies, by Host Species, 2028
Figure 51 : Rabbits Used in Research, Testing and Teaching in the U.S., 2012–2021
Figure 52 : Global Market for Rabbit Research Antibodies, 2020–2028
Figure 53 : Global Market for Rabbit Research Antibodies, by Region, 2020–2028
Figure 54 : Global Market for Goat Research Antibodies, 2020–2028
Figure 55 : Global Market for Goat Research Antibodies, by Region, 2020–2028
Figure 56 : Global Market for Mouse Research Antibodies, 2020–2028
Figure 57 : Global Market for Mouse Research Antibodies, by Region, 2020–2028
Figure 58 : Antigen-Antibody Interaction Between Mouse mAb and Four Human Enterovirus
Figure 59 : Global Market for Sheep Research Antibodies, 2020–2028
Figure 60 : Global Market for Sheep Research Antibodies, by Region, 2020–2028
Figure 61 : Global Market for Donkey Research Antibodies, 2020–2028
Figure 62 : Global Market for Donkey Research Antibodies, by Region, 2020–2028
Figure 63 : Global Market for Other Research Antibodies, 2020–2028
Figure 64 : Global Market for Other Research Antibodies, by Region, 2020–2028
Figure 65 : Global Market Shares of Research Antibodies, by End User, 2022
Figure 66 : Global Market Shares of Research Antibodies, by End User, 2028
Figure 67 : Global Incidence of Patients with Chronic Diseases, 2005–2030
Figure 68 : Global Market for Research Antibodies Used by Universities and Academic Institutions, 2020–2028
Figure 69 : Global Market for Research Antibodies Used by Universities and Academic Institutions, by Region, 2020–2028
Figure 70 : Global Market for Research Antibodies Used by Pharma and Biotech Companies, 2020–2028
Figure 71 : Global Market for Research Antibodies Used by Pharma and Biotech Companies, by Region, 2020–2028
Figure 72 : Global Market for Research Antibodies Used by Other End Users, 2020–2028
Figure 73 : Global Market for Research Antibodies Used by Other End Users, by Region, 2020–2028
Figure 74 : Global Market Shares of Research Antibodies, by Region, 2022
Figure 75 : Global Market Shares of Research Antibodies, by Region, 2028
Figure 76 : People Aged 65 Years or Older with Alzheimer’s Dementia in the U.S., 2023
Figure 77 : Alzheimer’s Disease Facts, 2023
Figure 78 : North American Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 79 : North American Market Shares of Research Antibodies, by Clonality, 2022
Figure 80 : North American Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 81 : North American Market Shares of Research Antibodies, by Application, 2022
Figure 82 : North American Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 83 : North American Market Shares of Research Antibodies, by Host Species, 2022
Figure 84 : North American Market Shares of Research Antibodies, by End User, 2022
Figure 85 : North American Market Shares of Research Antibodies, by Country, 2022
Figure 86 : U.S. Market for Research Antibodies, 2020–2028
Figure 87 : U.S. Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 88 : U.S. Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 89 : U.S. Market Shares of Research Antibodies, by Clonality, 2022
Figure 90 : U.S. Market Shares of Research Antibodies, by Clonality, 2028
Figure 91 : U.S. Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 92 : U.S. Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 93 : U.S. Market Shares of Research Antibodies, by Application, 2022
Figure 94 : U.S. Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 95 : U.S. Market Shares of Research Antibodies, by Application, 2028
Figure 96 : U.S. Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 97 : U.S. Market Shares of Research Antibodies, by Host Species, 2022
Figure 98 : U.S. Market Shares of Research Antibodies, by Host Species, 2028
Figure 99 : U.S. Market Shares of Research Antibodies, by End User, 2022
Figure 100 : U.S. Market Shares of Research Antibodies, by End User, 2028
Figure 101 : Canadian Market for Research Antibodies, 2020–2028
Figure 102 : Canadian Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 103 : Canadian Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 104 : Canadian Market Shares of Research Antibodies, by Clonality, 2022
Figure 105 : Canadian Market Shares of Research Antibodies, by Clonality, 2028
Figure 106 : Canadian Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 107 : Canadian Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 108 : Canadian Market Shares of Research Antibodies, by Application, 2022
Figure 109 : Canadian Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 110 : Canadian Market Shares of Research Antibodies, by Application, 2028
Figure 111 : Canadian Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 112 : Canadian Market Shares of Research Antibodies, by Host Species, 2022
Figure 113 : Canadian Market Shares of Research Antibodies, by Host Species, 2028
Figure 114 : Canadian Market Shares of Research Antibodies, by End User, 2022
Figure 115 : Canadian Market Shares of Research Antibodies, by End User, 2028
Figure 116 : Mexican Market for Research Antibodies, 2020–2028
Figure 117 : Mexican Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 118 : Mexican Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 119 : Mexican Market Shares of Research Antibodies, by Clonality, 2022
Figure 120 : Mexican Market Shares of Research Antibodies, by Clonality, 2028
Figure 121 : Mexican Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 122 : Mexican Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 123 : Mexican Market Shares of Research Antibodies, by Application, 2022
Figure 124 : Mexican Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 125 : Mexican Market Shares of Research Antibodies, by Application, 2028
Figure 126 : Mexican Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 127 : Mexican Market Shares of Research Antibodies, by Host Species, 2022
Figure 128 : Mexican Market Shares of Research Antibodies, by Host Species, 2028
Figure 129 : Mexican Market Shares of Research Antibodies, by End User, 2022
Figure 130 : Mexican Market Shares of Research Antibodies, by End User, 2028
Figure 131 : European Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 132 : European Market Shares of Research Antibodies, by Clonality, 2022
Figure 133 : European Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 134 : European Market Shares of Research Antibodies, by Application, 2022
Figure 135 : European Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 136 : European Market Shares of Research Antibodies, by Host Species, 2022
Figure 137 : European Market Shares of Research Antibodies, by End User, 2022
Figure 138 : European Market Shares of Research Antibodies, by Country, 2022
Figure 139 : German Market for Research Antibodies, 2020–2028
Figure 140 : German Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 141 : German Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 142 : German Market Shares of Research Antibodies, by Clonality, 2022
Figure 143 : German Market Shares of Research Antibodies, by Clonality, 2028
Figure 144 : German Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 145 : German Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 146 : German Market Shares of Research Antibodies, by Application, 2022
Figure 147 : German Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 148 : German Market Shares of Research Antibodies, by Application, 2028
Figure 149 : German Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 150 : German Market Shares of Research Antibodies, by Host Species, 2022
Figure 151 : German Market Shares of Research Antibodies, by Host Species, 2028
Figure 152 : German Market Shares of Research Antibodies, by End User, 2022
Figure 153 : German Market Shares of Research Antibodies, by End User, 2028
Figure 154 : German Global Health Spending, by Subsector, 2021
Figure 155 : German Global Health Spending, 2021
Figure 156 : French Market for Research Antibodies, 2020–2028
Figure 157 : French Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 158 : French Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 159 : French Market Shares of Research Antibodies, by Clonality, 2022
Figure 160 : French Market Shares of Research Antibodies, by Clonality, 2028
Figure 161 : French Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 162 : French Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 163 : French Market Shares of Research Antibodies, by Application, 2022
Figure 164 : French Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 165 : French Market Shares of Research Antibodies, by Application, 2028
Figure 166 : French Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 167 : French Market Shares of Research Antibodies, by Host Species, 2022
Figure 168 : French Market Shares of Research Antibodies, by Host Species, 2028
Figure 169 : French Market Shares for Research Antibodies, by End User, 2022
Figure 170 : French Market Shares of Research Antibodies, by End User, 2028
Figure 171 : France Expected Diagnosed Cancer for Women, 2020
Figure 172 : France Expected Diagnosed Cancer for Men, 2020
Figure 173 : French Health Spending and Financing, 2015–2020
Figure 174 : U.K. Market for Research Antibodies, 2020–2028
Figure 175 : U.K. Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 176 : U.K. Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 177 : U.K. Market Shares of Research Antibodies, by Clonality, 2022
Figure 178 : U.K. Market Shares of Research Antibodies, by Clonality, 2028
Figure 179 : U.K. Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 180 : U.K. Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 181 : U.K. Market Shares of Research Antibodies, by Application, 2022
Figure 182 : U.K. Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 183 : U.K. Market Shares of Research Antibodies, by Application, 2028
Figure 184 : U.K. Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 185 : U.K. Market Shares of Research Antibodies, by Host Species, 2022
Figure 186 : U.K. Market Shares of Research Antibodies, by Host Species, 2028
Figure 187 : U.K. Market Shares of Research Antibodies, by End User, 2022
Figure 188 : U.K. Market Shares of Research Antibodies, by End User, 2028
Figure 189 : Italian Market for Research Antibodies, 2020–2028
Figure 190 : Italian Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 191 : Italian Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 192 : Italian Market Shares of Research Antibodies, by Clonality, 2022
Figure 193 : Italian Market Shares of Research Antibodies, by Clonality, 2028
Figure 194 : Italian Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 195 : Italian Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 196 : Italian Market Shares of Research Antibodies, by Application, 2022
Figure 197 : Italian Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 198 : Italian Market Shares of Research Antibodies, by Application, 2028
Figure 199 : Italian Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 200 : Italian Market Shares of Research Antibodies, by Host Species, 2022
Figure 201 : Italian Market Shares of Research Antibodies, by Host Species, 2028
Figure 202 : Italian Market Shares of Research Antibodies, by End User, 2022
Figure 203 : Italian Market Shares of Research Antibodies, by End User, 2028
Figure 204 : Leading Subsectors in Italy, 2020
Figure 205 : Spanish Market for Research Antibodies, 2020–2028
Figure 206 : Spanish Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 207 : Spanish Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 208 : Spanish Market Shares of Research Antibodies, by Clonality, 2022
Figure 209 : Spanish Market Shares of Research Antibodies, by Clonality, 2028
Figure 210 : Spanish Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 211 : Spanish Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 212 : Spanish Market Shares of Research Antibodies, by Application, 2022
Figure 213 : Spanish Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 214 : Spanish Market Shares of Research Antibodies, by Application, 2028
Figure 215 : Spanish Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 216 : Spanish Market Shares of Research Antibodies, by Host Species, 2022
Figure 217 : Spanish Market Shares of Research Antibodies, by Host Species, 2028
Figure 218 : Spanish Market Shares of Research Antibodies, by End User, 2022
Figure 219 : Spanish Market Shares of Research Antibodies, by End User, 2028
Figure 220 : Rest of European Market for Research Antibodies, 2020–2028
Figure 221 : Rest of European Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 222 : Rest of European Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 223 : Rest of European Market Shares of Research Antibodies, by Clonality, 2022
Figure 224 : Rest of European Market Shares of Research Antibodies, by Clonality, 2028
Figure 225 : Rest of European Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 226 : Rest of European Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 227 : Rest of European Market Shares of Research Antibodies, by Application, 2022
Figure 228 : Rest of European Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 229 : Rest of European Market Shares of Research Antibodies, by Application, 2028
Figure 230 : Rest of European Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 231 : Rest of European Market Shares of Research Antibodies, by Host Species, 2022
Figure 232 : Rest of European Market Shares of Research Antibodies, by Host Species, 2028
Figure 233 : Rest of European Market Shares of Research Antibodies, by End User, 2022
Figure 234 : Rest of European Market Shares of Research Antibodies, by End User, 2028
Figure 235 : Asia-Pacific Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 236 : Asia-Pacific Market Shares of Research Antibodies, by Clonality, 2022
Figure 237 : Asia-Pacific Market Shares of Research Antibodies Market, by Major Reactivity, 2022
Figure 238 : Asia-Pacific Market Shares of Research Antibodies, by Application, 2022
Figure 239 : Asia-Pacific Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 240 : Asia-Pacific Market Shares of Research Antibodies, by Host Species, 2022
Figure 241 : Asia-Pacific Market Shares of Research Antibodies, by End User, 2022
Figure 242 : Regional Growth in Multi-specific Monoclonal Antibodies, by Region, 2018–2022
Figure 243 : Asia-Pacific Market Shares of Research Antibodies, by Country, 2022
Figure 244 : Japanese Market for Research Antibodies, 2020–2028
Figure 245 : Japanese Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 246 : Japanese Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 247 : Japanese Market Shares of Research Antibodies, by Clonality, 2022
Figure 248 : Japanese Market Shares of Research Antibodies, by Clonality, 2028
Figure 249 : Japanese Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 250 : Japanese Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 251 : Japanese Market Shares of Research Antibodies, by Application, 2022
Figure 252 : Japanese Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 253 : Japanese Market Shares of Research Antibodies, by Application, 2028
Figure 254 : Japanese Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 255 : Japanese Market Shares of Research Antibodies, by Host Species, 2022
Figure 256 : Japanese Market Shares of Research Antibodies, by Host Species, 2028
Figure 257 : Japanese Market Shares of Research Antibodies, by End User, 2022
Figure 258 : Japanese Market Shares of Research Antibodies, by End User, 2028
Figure 259 : Top Five Antibody Suppliers Shares in Japan, 2021
Figure 260 : Chinese Market for Research Antibodies, 2020–2028
Figure 261 : Chinese Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 262 : Chinese Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 263 : Chinese Market Shares of Research Antibodies, by Clonality, 2022
Figure 264 : Chinese Market Shares of Research Antibodies, by Clonality, 2028
Figure 265 : Chinese Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 266 : Chinese Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 267 : Chinese Market Shares of Research Antibodies, by Application, 2022
Figure 268 : Chinese Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 269 : Chinese Market Shares of Research Antibodies, by Application, 2028
Figure 270 : Chinese Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 271 : Chinese Market Shares of Research Antibodies, by Host Species, 2022
Figure 272 : Chinese Market Shares of Research Antibodies, by Host Species, 2028
Figure 273 : Chinese Market Shares of Research Antibodies, by End User, 2022
Figure 274 : Chinese Market Shares of Research Antibodies, by End User, 2028
Figure 275 : Chinese Market Growth Challenges, 2023
Figure 276 : Indian Market for Research Antibodies, 2020–2028
Figure 277 : Indian Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 278 : Indian Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 279 : Indian Market Shares of Research Antibodies, by Clonality, 2022
Figure 280 : Indian Market Shares of Research Antibodies, by Clonality, 2028
Figure 281 : Indian Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 282 : Indian Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 283 : Indian Market Shares of Research Antibodies, by Application, 2022
Figure 284 : Indian Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 285 : Indian Market Shares of Research Antibodies, by Application, 2028
Figure 286 : Indian Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 287 : Indian Market Shares of Research Antibodies, by Host Species, 2022
Figure 288 : Indian Market Shares of Research Antibodies, by Host Species, 2028
Figure 289 : Indian Market Shares of Research Antibodies, by End User, 2022
Figure 290 : Indian Market Shares of Research Antibodies, by End User, 2028
Figure 291 : Indian Market of Bioeconomy, 2021
Figure 292 : Indian Market of Bioeconomy’s Key Subsegment, 2021
Figure 293 : Australian and New Zealand Market for Research Antibodies, 2020–2028
Figure 294 : Australian and New Zealand Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 295 : Australian and New Zealand Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 296 : Australian and New Zealand Market Shares of Research Antibodies, by Clonality, 2022
Figure 297 : Australian and New Zealand Market Shares of Research Antibodies, by Clonality, 2028
Figure 298 : Australian and New Zealand Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 299 : Australian and New Zealand Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 300 : Australian and New Zealand Market Shares of Research Antibodies, by Application, 2022
Figure 301 : Australian and New Zealand Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 302 : Australian and New Zealand Market Shares of Research Antibodies, by Application, 2028
Figure 303 : Australian and New Zealand Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 304 : Australian and New Zealand Market Shares of Research Antibodies, by Host Species, 2022
Figure 305 : Australian and New Zealand Market Shares of Research Antibodies, by Host Species, 2028
Figure 306 : Australian and New Zealand Market Shares of Research Antibodies, by End User, 2022
Figure 307 : Australian and New Zealand Market Shares of Research Antibodies, by End User, 2028
Figure 308 : Australian and New Zealand Market Shares of Research Antibodies, by End User, 2028
Figure 309 : Rest of Asia-Pacific Market for Research Antibodies, 2020–2028
Figure 310 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 311 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 312 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Clonality, 2022
Figure 313 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Clonality, 2028
Figure 314 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 315 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 316 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Application, 2022
Figure 317 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 318 : Rest of Asia-Pacific Shares of Research Antibodies, by Application, 2028
Figure 319 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 320 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Host Species, 2022
Figure 321 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Host Species, 2028
Figure 322 : Rest of Asia-Pacific Market Shares of Research Antibodies, by End User, 2022
Figure 323 : Rest of Asia-Pacific Market Shares of Research Antibodies, by End User, 2028
Figure 324 : Rest of World Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 325 : Rest of World Market Shares of Research Antibodies, by Clonality, 2022
Figure 326 : Rest of World Market Shares of Research Antibodies Market, by Major Reactivity, 2022
Figure 327 : Rest of World Market Shares of Research Antibodies, by Application, 2022
Figure 328 : Rest of World Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 329 : Rest of World Market Shares of Research Antibodies, by Host Species, 2022
Figure 330 : Rest of World Market Shares of Research Antibodies, by End User, 2022
Figure 331 : Rest of the World Market Shares of Research Antibodies, by Country/Region, 2022
Figure 332 : Brazilian Market for Research Antibodies, 2020–2028
Figure 333 : Brazilian Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 334 : Brazilian Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 335 : Brazilian Market Shares of Research Antibodies, by Clonality, 2022
Figure 336 : Brazilian Market Shares of Research Antibodies, by Clonality, 2028
Figure 337 : Brazilian Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 338 : Brazilian Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 339 : Brazilian Market Shares of Research Antibodies, by Application, 2022
Figure 340 : Brazilian Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 341 : Brazilian Market Shares of Research Antibodies, by Application, 2028
Figure 342 : Brazilian Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 343 : Brazilian Market Shares of Research Antibodies, by Host Species, 2022
Figure 344 : Brazilian Market Shares of Research Antibodies, by Host Species, 2028
Figure 345 : Brazilian Market Shares of Research Antibodies, by End User, 2022
Figure 346 : Brazilian Market Shares of Research Antibodies, by End User, 2028
Figure 347 : GCC Countries Market for Research Antibodies, 2020–2028
Figure 348 : GCC countries Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 349 : GCC Countries Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 350 : GCC Countries Market Shares of Research Antibodies, by Clonality, 2022
Figure 351 : GCC Countries Market Shares of Research Antibodies, by Clonality, 2028
Figure 352 : GCC Countries Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 353 : GCC Countries Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 354 : GCC countries Market Shares of Research Antibodies, by Application, 2022
Figure 355 : GCC Countries Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 356 : GCC Countries Market Shares of Research Antibodies, by Application, 2028
Figure 357 : GCC Countries Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 358 : GCC Countries Market Shares of Research Antibodies, by Host Species, 2022
Figure 359 : GCC Countries Market Shares of Research Antibodies, by Host Species, 2028
Figure 360 : GCC Countries Market Shares of Research Antibodies, by End User, 2022
Figure 361 : GCC Countries Market Shares of Research Antibodies, by End User, 2028
Figure 362 : Rest of World Countries Market for Research Antibodies, 2020–2028
Figure 363 : Rest of World Countries Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 364 : Rest of World Countries Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 365 : Rest of World Countries Market Shares of Research Antibodies, by Clonality, 2022
Figure 366 : Rest of World Countries Market Shares of Research Antibodies, by Clonality, 2028
Figure 367 : Rest of World Countries Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 368 : Rest of World Countries Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 369 : Rest of World Countries Market Shares of Research Antibodies, by Application, 2022
Figure 370 : Rest of World Countries Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 371 : Rest of World Countries Market Shares of Research Antibodies, by Application, 2028
Figure 372 : Rest of World Countries Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 373 : Rest of World Countries Market Shares of Research Antibodies, by Host Species, 2022
Figure 374 : Rest of World Countries Market Shares of Research Antibodies, by Host Species, 2028
Figure 375 : Rest of World Countries Market Shares of Research Antibodies, by End User, 2022
Figure 376 : Rest of World Countries Market Shares of Research Antibodies, by End User, 2028
Figure 377 : U.S. versus the Rest of the World Market Shares of Monoclonal Antibodies, 2021
Figure 378 : Snapshot: Key Environmental, Social and Governance Trends in the Research Antibodies Industry
Figure 379 : Snapshot: Key Environmental, Social and Governance Trends in the Research Antibodies Industry
Figure 380 : Merck’s ESG Priorities Matrix, 2022
Figure 381 : Bio-Rad ESG Priorities Matrix, 2022
Figure 382 : Schematic Illustration of Traditional Strategies for Antibody Discovery and Generation
Figure 383 : Schematic Illustration of Emerging Strategies for Antibody Discovery and Generation
Figure 384 : Snapshot: Key Trends in the Growth of Antibody Production Technologies
Figure 385 : Classification of Soft Computing Approaches
Figure 386 : Global Market Ranking of Manufacturers of Research Antibodies, 2022
Figure 387 : Distribution of Anti-SARS-CoV-2 Immunoglobulin
Figure 388 : Top 100 Antibodies, 2022
Figure 389 : Abcam plc.: Annual Revenue, 2020–2022
Figure 390 : Abcam plc.: Revenue Shares, by Region, 2022
Figure 391 : Abcam plc.: Revenue Shares, by Business Segment, 2022
Figure 392 : Agilent Technologies Inc.: Annual Revenue, 2016–2022
Figure 393 : Agilent Technologies Inc.: Revenue Shares, by Region, 2022
Figure 394 : Agilent Technologies Inc.: Revenue Shares, by Business Segment, 2022
Figure 395 : BD Biosciences: Annual Revenue, 2019–2022
Figure 396 : BD Biosciences: Revenue Shares, by Region, 2022
Figure 397 : BD Biosciences: Revenue Shares, by Business Segments, 2022
Figure 398 : Bio-Rad: Annual Revenue, 2019–2022
Figure 399 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, 2022
Figure 400 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, 2022
Figure 401 : Bio-Techne: Annual Revenue, 2016–2022
Summary Figure : Global Market Shares of Research Antibodies, by Application, 2022
Figure :
Figure 1 : Global Markets for Research Antibodies Market Dynamics
Figure 2 : Global Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 3 : Global Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 4 : Global Market for Primary Antibodies, 2020–2028
Figure 5 : Global Market for Primary Antibodies, by Region, 2020–2028
Figure 6 : Global Market for Secondary Antibodies, 2020–2028
Figure 7 : Global Market for Secondary Antibodies, by Region, 2020–2028
Figure 8 : Global Market Shares of Research Antibodies, by Clonality, 2022
Figure 9 : Global Market Shares of Research Antibodies, by Clonality, 2028
Figure 10 : Global Market for Polyclonal Antibodies, 2020–2028
Figure 11 : Global Market for Polyclonal Antibodies, by Region, 2020–2028
Figure 12 : Global Market for Monoclonal Antibodies, 2020–2028
Figure 13 : Global Market for Monoclonal Antibodies, by Region, 2020–2028
Figure 14 : Global Market for Recombinant Antibodies, 2020–2028
Figure 15 : Global Market for Recombinant Antibodies, by Region, 2020–2028
Figure 16 : Global Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 17 : Global Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 18 : Global Market for Anti-Human Antibodies, 2020–2028
Figure 19 : Global Market for Anti-Human Antibodies, by Region, 2020–2028
Figure 20 : Global Market for Anti-Mouse Antibodies, 2020–2028
Figure 21 : Global Market for Anti-Mouse Antibodies, by Region, 2020–2028
Figure 22 : Global Market for Anti-Rat Antibodies, 2020–2028
Figure 23 : Global Market for Anti-Rat Antibodies, by Region, 2020–2028
Figure 24 : Global Market for Other Research Antibodies, 2020–2028
Figure 25 : Global Market for Other Research Antibodies, by Region, 2020–2028
Figure 26 : Global Market Shares of Research Antibodies, by Application, 2022
Figure 27 : Global Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 28 : Global Market Shares of Research Antibodies, by Application, 2028
Figure 29 : Global Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 30 : Global Market for Western Blot Applications, 2020–2028
Figure 31 : Global Market for Western Blot Applications, by Region, 2020–2028
Figure 32 : Global Market for Flow Cytometry Applications, 2020–2028
Figure 33 : Global Market for Flow Cytometry Applications, by Region, 2020–2028
Figure 34 : Estimated New Cases of Leukemia, Lymphoma and Myeloma, 2020
Figure 35 : Global Market for Immunohistochemistry Applications, 2020–2028
Figure 36 : Global Market for Immunohistochemistry Applications, by Region, 2020–2028
Figure 37 : Global Market for Multiplex Staining Applications, 2020–2028
Figure 38 : Global Market for Multiplex Staining Applications, by Region, 2020–2028
Figure 39 : Global Market for Low-Flexed Staining Applications, 2020–2028
Figure 40 : Global Market for Low-Flexed Staining Applications, by Region, 2020–2028
Figure 41 : Global Market for Immunocytochemistry Applications, 2020–2028
Figure 42 : Global Market for Immunocytochemistry Applications, by Region, 2020–2028
Figure 43 : Global Market for Immunofluorescent Applications, 2020–2028
Figure 44 : Global Market for Immunofluorescent Applications, by Region, 2020–2028
Figure 45 : Global Market for Immunoprecipitation Applications, 2020–2028
Figure 46 : Global Market for Immunoprecipitation Applications, by Region, 2020–2028
Figure 47 : Global Market for ELISA Applications, 2020–2028
Figure 48 : Global Market for ELISA Applications, by Region, 2020–2028
Figure 49 : Global Market Shares of Research Antibodies, by Host Species, 2022
Figure 50 : Global Market Shares of Research Antibodies, by Host Species, 2028
Figure 51 : Rabbits Used in Research, Testing and Teaching in the U.S., 2012–2021
Figure 52 : Global Market for Rabbit Research Antibodies, 2020–2028
Figure 53 : Global Market for Rabbit Research Antibodies, by Region, 2020–2028
Figure 54 : Global Market for Goat Research Antibodies, 2020–2028
Figure 55 : Global Market for Goat Research Antibodies, by Region, 2020–2028
Figure 56 : Global Market for Mouse Research Antibodies, 2020–2028
Figure 57 : Global Market for Mouse Research Antibodies, by Region, 2020–2028
Figure 58 : Antigen-Antibody Interaction Between Mouse mAb and Four Human Enterovirus
Figure 59 : Global Market for Sheep Research Antibodies, 2020–2028
Figure 60 : Global Market for Sheep Research Antibodies, by Region, 2020–2028
Figure 61 : Global Market for Donkey Research Antibodies, 2020–2028
Figure 62 : Global Market for Donkey Research Antibodies, by Region, 2020–2028
Figure 63 : Global Market for Other Research Antibodies, 2020–2028
Figure 64 : Global Market for Other Research Antibodies, by Region, 2020–2028
Figure 65 : Global Market Shares of Research Antibodies, by End User, 2022
Figure 66 : Global Market Shares of Research Antibodies, by End User, 2028
Figure 67 : Global Incidence of Patients with Chronic Diseases, 2005–2030
Figure 68 : Global Market for Research Antibodies Used by Universities and Academic Institutions, 2020–2028
Figure 69 : Global Market for Research Antibodies Used by Universities and Academic Institutions, by Region, 2020–2028
Figure 70 : Global Market for Research Antibodies Used by Pharma and Biotech Companies, 2020–2028
Figure 71 : Global Market for Research Antibodies Used by Pharma and Biotech Companies, by Region, 2020–2028
Figure 72 : Global Market for Research Antibodies Used by Other End Users, 2020–2028
Figure 73 : Global Market for Research Antibodies Used by Other End Users, by Region, 2020–2028
Figure 74 : Global Market Shares of Research Antibodies, by Region, 2022
Figure 75 : Global Market Shares of Research Antibodies, by Region, 2028
Figure 76 : People Aged 65 Years or Older with Alzheimer’s Dementia in the U.S., 2023
Figure 77 : Alzheimer’s Disease Facts, 2023
Figure 78 : North American Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 79 : North American Market Shares of Research Antibodies, by Clonality, 2022
Figure 80 : North American Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 81 : North American Market Shares of Research Antibodies, by Application, 2022
Figure 82 : North American Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 83 : North American Market Shares of Research Antibodies, by Host Species, 2022
Figure 84 : North American Market Shares of Research Antibodies, by End User, 2022
Figure 85 : North American Market Shares of Research Antibodies, by Country, 2022
Figure 86 : U.S. Market for Research Antibodies, 2020–2028
Figure 87 : U.S. Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 88 : U.S. Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 89 : U.S. Market Shares of Research Antibodies, by Clonality, 2022
Figure 90 : U.S. Market Shares of Research Antibodies, by Clonality, 2028
Figure 91 : U.S. Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 92 : U.S. Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 93 : U.S. Market Shares of Research Antibodies, by Application, 2022
Figure 94 : U.S. Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 95 : U.S. Market Shares of Research Antibodies, by Application, 2028
Figure 96 : U.S. Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 97 : U.S. Market Shares of Research Antibodies, by Host Species, 2022
Figure 98 : U.S. Market Shares of Research Antibodies, by Host Species, 2028
Figure 99 : U.S. Market Shares of Research Antibodies, by End User, 2022
Figure 100 : U.S. Market Shares of Research Antibodies, by End User, 2028
Figure 101 : Canadian Market for Research Antibodies, 2020–2028
Figure 102 : Canadian Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 103 : Canadian Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 104 : Canadian Market Shares of Research Antibodies, by Clonality, 2022
Figure 105 : Canadian Market Shares of Research Antibodies, by Clonality, 2028
Figure 106 : Canadian Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 107 : Canadian Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 108 : Canadian Market Shares of Research Antibodies, by Application, 2022
Figure 109 : Canadian Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 110 : Canadian Market Shares of Research Antibodies, by Application, 2028
Figure 111 : Canadian Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 112 : Canadian Market Shares of Research Antibodies, by Host Species, 2022
Figure 113 : Canadian Market Shares of Research Antibodies, by Host Species, 2028
Figure 114 : Canadian Market Shares of Research Antibodies, by End User, 2022
Figure 115 : Canadian Market Shares of Research Antibodies, by End User, 2028
Figure 116 : Mexican Market for Research Antibodies, 2020–2028
Figure 117 : Mexican Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 118 : Mexican Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 119 : Mexican Market Shares of Research Antibodies, by Clonality, 2022
Figure 120 : Mexican Market Shares of Research Antibodies, by Clonality, 2028
Figure 121 : Mexican Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 122 : Mexican Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 123 : Mexican Market Shares of Research Antibodies, by Application, 2022
Figure 124 : Mexican Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 125 : Mexican Market Shares of Research Antibodies, by Application, 2028
Figure 126 : Mexican Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 127 : Mexican Market Shares of Research Antibodies, by Host Species, 2022
Figure 128 : Mexican Market Shares of Research Antibodies, by Host Species, 2028
Figure 129 : Mexican Market Shares of Research Antibodies, by End User, 2022
Figure 130 : Mexican Market Shares of Research Antibodies, by End User, 2028
Figure 131 : European Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 132 : European Market Shares of Research Antibodies, by Clonality, 2022
Figure 133 : European Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 134 : European Market Shares of Research Antibodies, by Application, 2022
Figure 135 : European Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 136 : European Market Shares of Research Antibodies, by Host Species, 2022
Figure 137 : European Market Shares of Research Antibodies, by End User, 2022
Figure 138 : European Market Shares of Research Antibodies, by Country, 2022
Figure 139 : German Market for Research Antibodies, 2020–2028
Figure 140 : German Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 141 : German Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 142 : German Market Shares of Research Antibodies, by Clonality, 2022
Figure 143 : German Market Shares of Research Antibodies, by Clonality, 2028
Figure 144 : German Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 145 : German Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 146 : German Market Shares of Research Antibodies, by Application, 2022
Figure 147 : German Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 148 : German Market Shares of Research Antibodies, by Application, 2028
Figure 149 : German Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 150 : German Market Shares of Research Antibodies, by Host Species, 2022
Figure 151 : German Market Shares of Research Antibodies, by Host Species, 2028
Figure 152 : German Market Shares of Research Antibodies, by End User, 2022
Figure 153 : German Market Shares of Research Antibodies, by End User, 2028
Figure 154 : German Global Health Spending, by Subsector, 2021
Figure 155 : German Global Health Spending, 2021
Figure 156 : French Market for Research Antibodies, 2020–2028
Figure 157 : French Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 158 : French Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 159 : French Market Shares of Research Antibodies, by Clonality, 2022
Figure 160 : French Market Shares of Research Antibodies, by Clonality, 2028
Figure 161 : French Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 162 : French Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 163 : French Market Shares of Research Antibodies, by Application, 2022
Figure 164 : French Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 165 : French Market Shares of Research Antibodies, by Application, 2028
Figure 166 : French Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 167 : French Market Shares of Research Antibodies, by Host Species, 2022
Figure 168 : French Market Shares of Research Antibodies, by Host Species, 2028
Figure 169 : French Market Shares for Research Antibodies, by End User, 2022
Figure 170 : French Market Shares of Research Antibodies, by End User, 2028
Figure 171 : France Expected Diagnosed Cancer for Women, 2020
Figure 172 : France Expected Diagnosed Cancer for Men, 2020
Figure 173 : French Health Spending and Financing, 2015–2020
Figure 174 : U.K. Market for Research Antibodies, 2020–2028
Figure 175 : U.K. Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 176 : U.K. Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 177 : U.K. Market Shares of Research Antibodies, by Clonality, 2022
Figure 178 : U.K. Market Shares of Research Antibodies, by Clonality, 2028
Figure 179 : U.K. Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 180 : U.K. Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 181 : U.K. Market Shares of Research Antibodies, by Application, 2022
Figure 182 : U.K. Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 183 : U.K. Market Shares of Research Antibodies, by Application, 2028
Figure 184 : U.K. Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 185 : U.K. Market Shares of Research Antibodies, by Host Species, 2022
Figure 186 : U.K. Market Shares of Research Antibodies, by Host Species, 2028
Figure 187 : U.K. Market Shares of Research Antibodies, by End User, 2022
Figure 188 : U.K. Market Shares of Research Antibodies, by End User, 2028
Figure 189 : Italian Market for Research Antibodies, 2020–2028
Figure 190 : Italian Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 191 : Italian Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 192 : Italian Market Shares of Research Antibodies, by Clonality, 2022
Figure 193 : Italian Market Shares of Research Antibodies, by Clonality, 2028
Figure 194 : Italian Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 195 : Italian Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 196 : Italian Market Shares of Research Antibodies, by Application, 2022
Figure 197 : Italian Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 198 : Italian Market Shares of Research Antibodies, by Application, 2028
Figure 199 : Italian Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 200 : Italian Market Shares of Research Antibodies, by Host Species, 2022
Figure 201 : Italian Market Shares of Research Antibodies, by Host Species, 2028
Figure 202 : Italian Market Shares of Research Antibodies, by End User, 2022
Figure 203 : Italian Market Shares of Research Antibodies, by End User, 2028
Figure 204 : Leading Subsectors in Italy, 2020
Figure 205 : Spanish Market for Research Antibodies, 2020–2028
Figure 206 : Spanish Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 207 : Spanish Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 208 : Spanish Market Shares of Research Antibodies, by Clonality, 2022
Figure 209 : Spanish Market Shares of Research Antibodies, by Clonality, 2028
Figure 210 : Spanish Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 211 : Spanish Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 212 : Spanish Market Shares of Research Antibodies, by Application, 2022
Figure 213 : Spanish Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 214 : Spanish Market Shares of Research Antibodies, by Application, 2028
Figure 215 : Spanish Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 216 : Spanish Market Shares of Research Antibodies, by Host Species, 2022
Figure 217 : Spanish Market Shares of Research Antibodies, by Host Species, 2028
Figure 218 : Spanish Market Shares of Research Antibodies, by End User, 2022
Figure 219 : Spanish Market Shares of Research Antibodies, by End User, 2028
Figure 220 : Rest of European Market for Research Antibodies, 2020–2028
Figure 221 : Rest of European Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 222 : Rest of European Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 223 : Rest of European Market Shares of Research Antibodies, by Clonality, 2022
Figure 224 : Rest of European Market Shares of Research Antibodies, by Clonality, 2028
Figure 225 : Rest of European Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 226 : Rest of European Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 227 : Rest of European Market Shares of Research Antibodies, by Application, 2022
Figure 228 : Rest of European Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 229 : Rest of European Market Shares of Research Antibodies, by Application, 2028
Figure 230 : Rest of European Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 231 : Rest of European Market Shares of Research Antibodies, by Host Species, 2022
Figure 232 : Rest of European Market Shares of Research Antibodies, by Host Species, 2028
Figure 233 : Rest of European Market Shares of Research Antibodies, by End User, 2022
Figure 234 : Rest of European Market Shares of Research Antibodies, by End User, 2028
Figure 235 : Asia-Pacific Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 236 : Asia-Pacific Market Shares of Research Antibodies, by Clonality, 2022
Figure 237 : Asia-Pacific Market Shares of Research Antibodies Market, by Major Reactivity, 2022
Figure 238 : Asia-Pacific Market Shares of Research Antibodies, by Application, 2022
Figure 239 : Asia-Pacific Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 240 : Asia-Pacific Market Shares of Research Antibodies, by Host Species, 2022
Figure 241 : Asia-Pacific Market Shares of Research Antibodies, by End User, 2022
Figure 242 : Regional Growth in Multi-specific Monoclonal Antibodies, by Region, 2018–2022
Figure 243 : Asia-Pacific Market Shares of Research Antibodies, by Country, 2022
Figure 244 : Japanese Market for Research Antibodies, 2020–2028
Figure 245 : Japanese Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 246 : Japanese Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 247 : Japanese Market Shares of Research Antibodies, by Clonality, 2022
Figure 248 : Japanese Market Shares of Research Antibodies, by Clonality, 2028
Figure 249 : Japanese Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 250 : Japanese Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 251 : Japanese Market Shares of Research Antibodies, by Application, 2022
Figure 252 : Japanese Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 253 : Japanese Market Shares of Research Antibodies, by Application, 2028
Figure 254 : Japanese Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 255 : Japanese Market Shares of Research Antibodies, by Host Species, 2022
Figure 256 : Japanese Market Shares of Research Antibodies, by Host Species, 2028
Figure 257 : Japanese Market Shares of Research Antibodies, by End User, 2022
Figure 258 : Japanese Market Shares of Research Antibodies, by End User, 2028
Figure 259 : Top Five Antibody Suppliers Shares in Japan, 2021
Figure 260 : Chinese Market for Research Antibodies, 2020–2028
Figure 261 : Chinese Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 262 : Chinese Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 263 : Chinese Market Shares of Research Antibodies, by Clonality, 2022
Figure 264 : Chinese Market Shares of Research Antibodies, by Clonality, 2028
Figure 265 : Chinese Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 266 : Chinese Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 267 : Chinese Market Shares of Research Antibodies, by Application, 2022
Figure 268 : Chinese Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 269 : Chinese Market Shares of Research Antibodies, by Application, 2028
Figure 270 : Chinese Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 271 : Chinese Market Shares of Research Antibodies, by Host Species, 2022
Figure 272 : Chinese Market Shares of Research Antibodies, by Host Species, 2028
Figure 273 : Chinese Market Shares of Research Antibodies, by End User, 2022
Figure 274 : Chinese Market Shares of Research Antibodies, by End User, 2028
Figure 275 : Chinese Market Growth Challenges, 2023
Figure 276 : Indian Market for Research Antibodies, 2020–2028
Figure 277 : Indian Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 278 : Indian Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 279 : Indian Market Shares of Research Antibodies, by Clonality, 2022
Figure 280 : Indian Market Shares of Research Antibodies, by Clonality, 2028
Figure 281 : Indian Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 282 : Indian Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 283 : Indian Market Shares of Research Antibodies, by Application, 2022
Figure 284 : Indian Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 285 : Indian Market Shares of Research Antibodies, by Application, 2028
Figure 286 : Indian Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 287 : Indian Market Shares of Research Antibodies, by Host Species, 2022
Figure 288 : Indian Market Shares of Research Antibodies, by Host Species, 2028
Figure 289 : Indian Market Shares of Research Antibodies, by End User, 2022
Figure 290 : Indian Market Shares of Research Antibodies, by End User, 2028
Figure 291 : Indian Market of Bioeconomy, 2021
Figure 292 : Indian Market of Bioeconomy’s Key Subsegment, 2021
Figure 293 : Australian and New Zealand Market for Research Antibodies, 2020–2028
Figure 294 : Australian and New Zealand Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 295 : Australian and New Zealand Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 296 : Australian and New Zealand Market Shares of Research Antibodies, by Clonality, 2022
Figure 297 : Australian and New Zealand Market Shares of Research Antibodies, by Clonality, 2028
Figure 298 : Australian and New Zealand Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 299 : Australian and New Zealand Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 300 : Australian and New Zealand Market Shares of Research Antibodies, by Application, 2022
Figure 301 : Australian and New Zealand Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 302 : Australian and New Zealand Market Shares of Research Antibodies, by Application, 2028
Figure 303 : Australian and New Zealand Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 304 : Australian and New Zealand Market Shares of Research Antibodies, by Host Species, 2022
Figure 305 : Australian and New Zealand Market Shares of Research Antibodies, by Host Species, 2028
Figure 306 : Australian and New Zealand Market Shares of Research Antibodies, by End User, 2022
Figure 307 : Australian and New Zealand Market Shares of Research Antibodies, by End User, 2028
Figure 308 : Australian and New Zealand Market Shares of Research Antibodies, by End User, 2028
Figure 309 : Rest of Asia-Pacific Market for Research Antibodies, 2020–2028
Figure 310 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 311 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 312 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Clonality, 2022
Figure 313 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Clonality, 2028
Figure 314 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 315 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 316 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Application, 2022
Figure 317 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 318 : Rest of Asia-Pacific Shares of Research Antibodies, by Application, 2028
Figure 319 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 320 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Host Species, 2022
Figure 321 : Rest of Asia-Pacific Market Shares of Research Antibodies, by Host Species, 2028
Figure 322 : Rest of Asia-Pacific Market Shares of Research Antibodies, by End User, 2022
Figure 323 : Rest of Asia-Pacific Market Shares of Research Antibodies, by End User, 2028
Figure 324 : Rest of World Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 325 : Rest of World Market Shares of Research Antibodies, by Clonality, 2022
Figure 326 : Rest of World Market Shares of Research Antibodies Market, by Major Reactivity, 2022
Figure 327 : Rest of World Market Shares of Research Antibodies, by Application, 2022
Figure 328 : Rest of World Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 329 : Rest of World Market Shares of Research Antibodies, by Host Species, 2022
Figure 330 : Rest of World Market Shares of Research Antibodies, by End User, 2022
Figure 331 : Rest of the World Market Shares of Research Antibodies, by Country/Region, 2022
Figure 332 : Brazilian Market for Research Antibodies, 2020–2028
Figure 333 : Brazilian Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 334 : Brazilian Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 335 : Brazilian Market Shares of Research Antibodies, by Clonality, 2022
Figure 336 : Brazilian Market Shares of Research Antibodies, by Clonality, 2028
Figure 337 : Brazilian Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 338 : Brazilian Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 339 : Brazilian Market Shares of Research Antibodies, by Application, 2022
Figure 340 : Brazilian Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 341 : Brazilian Market Shares of Research Antibodies, by Application, 2028
Figure 342 : Brazilian Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 343 : Brazilian Market Shares of Research Antibodies, by Host Species, 2022
Figure 344 : Brazilian Market Shares of Research Antibodies, by Host Species, 2028
Figure 345 : Brazilian Market Shares of Research Antibodies, by End User, 2022
Figure 346 : Brazilian Market Shares of Research Antibodies, by End User, 2028
Figure 347 : GCC Countries Market for Research Antibodies, 2020–2028
Figure 348 : GCC countries Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 349 : GCC Countries Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 350 : GCC Countries Market Shares of Research Antibodies, by Clonality, 2022
Figure 351 : GCC Countries Market Shares of Research Antibodies, by Clonality, 2028
Figure 352 : GCC Countries Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 353 : GCC Countries Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 354 : GCC countries Market Shares of Research Antibodies, by Application, 2022
Figure 355 : GCC Countries Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 356 : GCC Countries Market Shares of Research Antibodies, by Application, 2028
Figure 357 : GCC Countries Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 358 : GCC Countries Market Shares of Research Antibodies, by Host Species, 2022
Figure 359 : GCC Countries Market Shares of Research Antibodies, by Host Species, 2028
Figure 360 : GCC Countries Market Shares of Research Antibodies, by End User, 2022
Figure 361 : GCC Countries Market Shares of Research Antibodies, by End User, 2028
Figure 362 : Rest of World Countries Market for Research Antibodies, 2020–2028
Figure 363 : Rest of World Countries Market Shares of Research Antibodies, by Type of Antibody, 2022
Figure 364 : Rest of World Countries Market Shares of Research Antibodies, by Type of Antibody, 2028
Figure 365 : Rest of World Countries Market Shares of Research Antibodies, by Clonality, 2022
Figure 366 : Rest of World Countries Market Shares of Research Antibodies, by Clonality, 2028
Figure 367 : Rest of World Countries Market Shares of Research Antibodies, by Major Reactivity, 2022
Figure 368 : Rest of World Countries Market Shares of Research Antibodies, by Major Reactivity, 2028
Figure 369 : Rest of World Countries Market Shares of Research Antibodies, by Application, 2022
Figure 370 : Rest of World Countries Market Shares of Research Antibodies, by Immunohistochemistry, 2022
Figure 371 : Rest of World Countries Market Shares of Research Antibodies, by Application, 2028
Figure 372 : Rest of World Countries Market Shares of Research Antibodies, by Immunohistochemistry, 2028
Figure 373 : Rest of World Countries Market Shares of Research Antibodies, by Host Species, 2022
Figure 374 : Rest of World Countries Market Shares of Research Antibodies, by Host Species, 2028
Figure 375 : Rest of World Countries Market Shares of Research Antibodies, by End User, 2022
Figure 376 : Rest of World Countries Market Shares of Research Antibodies, by End User, 2028
Figure 377 : U.S. versus the Rest of the World Market Shares of Monoclonal Antibodies, 2021
Figure 378 : Snapshot: Key Environmental, Social and Governance Trends in the Research Antibodies Industry
Figure 379 : Snapshot: Key Environmental, Social and Governance Trends in the Research Antibodies Industry
Figure 380 : Merck’s ESG Priorities Matrix, 2022
Figure 381 : Bio-Rad ESG Priorities Matrix, 2022
Figure 382 : Schematic Illustration of Traditional Strategies for Antibody Discovery and Generation
Figure 383 : Schematic Illustration of Emerging Strategies for Antibody Discovery and Generation
Figure 384 : Snapshot: Key Trends in the Growth of Antibody Production Technologies
Figure 385 : Classification of Soft Computing Approaches
Figure 386 : Global Market Ranking of Manufacturers of Research Antibodies, 2022
Figure 387 : Distribution of Anti-SARS-CoV-2 Immunoglobulin
Figure 388 : Top 100 Antibodies, 2022
Figure 389 : Abcam plc.: Annual Revenue, 2020–2022
Figure 390 : Abcam plc.: Revenue Shares, by Region, 2022
Figure 391 : Abcam plc.: Revenue Shares, by Business Segment, 2022
Figure 392 : Agilent Technologies Inc.: Annual Revenue, 2016–2022
Figure 393 : Agilent Technologies Inc.: Revenue Shares, by Region, 2022
Figure 394 : Agilent Technologies Inc.: Revenue Shares, by Business Segment, 2022
Figure 395 : BD Biosciences: Annual Revenue, 2019–2022
Figure 396 : BD Biosciences: Revenue Shares, by Region, 2022
Figure 397 : BD Biosciences: Revenue Shares, by Business Segments, 2022
Figure 398 : Bio-Rad: Annual Revenue, 2019–2022
Figure 399 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, 2022
Figure 400 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, 2022
Figure 401 : Bio-Techne: Annual Revenue, 2016–2022
